Neutralizing anti-AAV antibody impact on vector transduction following intravitreal administration of AAV in non-human primates

被引：0
|
作者：
Shearman, M. S. [1 ]
Turunen, H. T. [1 ]
Newmark, J. [1 ]
Pennock, S. [1 ]
Timmers, A.
机构：
[1] AGTC, Alachua, FL USA
来源：
HUMAN GENE THERAPY | 2019年 / 30卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P335
引用
收藏
页码：A115 / A116
页数：2
相关论文
共 50 条
  • [31] Threshold dose of factor IX expression in non-human primates following IV administration of AAV8 vectors
    Mizukami, Hiroaki
    Mimuro, Jun
    Tsukahara, Tomonori
    Urabe, Masashi
    Kume, Akihiro
    Ohmori, Tsukasa
    Madoiwa, Seiji
    Sakata, Yoichi
    Ozawa, Keiya
    HUMAN GENE THERAPY, 2012, 23 (10) : A77 - A78
  • [32] Subfoveal Injections in Non-Human Primates: Safety and Efficacy Following Administration of a Photoreceptor-Targeted AAV5
    Boyd, Ryan F.
    Bartoe, Joshua T.
    Vihtelic, Thomas S.
    Boye, Sanford L.
    Boye, Shannon Elizabeth
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [33] Expanding the AAV Toolbox for Cerebellar Transduction: Identifying and Characterizing Novel Variants in Non-Human Primates and Mice
    Keiser, Megan S.
    Chen, Yong Hong
    Ranum, Paul T.
    Liu, Xueyuan
    Cheng, Congsheng
    Leib, David
    Smith, Geary
    Muehlmatt, Amy
    Tecedor, Luis
    Davidson, Beverly L.
    MOLECULAR THERAPY, 2021, 29 (04) : 27 - 27
  • [34] Immunological response and durability of expression following sequential intravitreal administration of AAV2.7m8 gene therapy to the contralateral eye in non-human primates
    Cepeda, Diana
    Yeh, Edward
    Nieves, Julio
    Diaz, Carolina Ceballos
    Rosario, Awilda
    Greengard, Judith
    Gelfman, Claire
    Gasmi, Mehdi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [35] Successful repeated hepatic gene delivery in mice and non-human primates achieved by sequential administration of AAV2/5 and AAV1 vector serotypes
    Majowicz, Anna
    Salas, David
    Aseguinolaza, Gloria Gonzalez
    Petry, Harald
    Ferreira, Valerie
    HUMAN GENE THERAPY, 2014, 25 (11) : A53 - A53
  • [36] Para-Retinal Administration of AAV204, a Novel AAV Capsid for the Treatment of Inherited Retinal Dystrophies, in Non-Human Primates
    Kevany, Brian
    Kerns, Scott
    Padegimas, Linas
    MOLECULAR THERAPY, 2022, 30 (04) : 436 - 437
  • [37] Evaluating the degree of HSPG-binding for effective AAV transduction following intravitreal administration
    Neal, T.
    Tseng, Y.
    Otoc, N.
    Chavez, C. L.
    Gasmi, M.
    Keravala, A.
    HUMAN GENE THERAPY, 2016, 27 (11) : A121 - A121
  • [38] AAV9 biodistribution and expression in the PNS of Non-Human Primates
    Kagiava, A.
    Casy, W.
    Trygg, C.
    Braun, S. E.
    Gray, S. J.
    Kleopa, K. A.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A37 - A37
  • [39] Safety and efficacy of AAV5-hFIX in non-human primates
    Nijmeijer, Bart
    Petry, Harald
    Spronck, Lisa
    van der Kruijssen, Corina
    Salmon, Florence
    HUMAN GENE THERAPY, 2014, 25 (11) : A38 - A38
  • [40] Human Polyclonal Anti-AAV Neutralizing Antibody Epitope Mapping by NGS Identifies Common Epitopes and Enables the Design of Stealth Mutants
    Baggett, Helen R.
    Chang, Xiao Lan
    Adachi, Kei
    Nakai, Hiroyuki
    MOLECULAR THERAPY, 2019, 27 (04) : 187 - 187
12345